Organon targets $1B in Nexplanon revenue for 2025 while advancing Vtama expansion
Vtama is projected to contribute $150 million in 2025 revenue, supported by its new label approval for atopic dermatitis. Nexplanon is expected to reach at least $1 billion in revenue for 2025. Q4 ...
Cardiac Tissue Engineering Market 2025 Top Business Strategy, Growth Factors, Healthy CAGR with Segments & Forecast with Top 5 Key Players Analysis
Prominent players in the Cardiac Tissue Engineering market include, Terumo corporation (Japan), Artivion, Inc. (US), Baxter ...
Gilead Sciences (GILD) Q4 2024 Earnings Call Transcript
Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...
Gilead Sciences, Inc. (GILD) Q4 2024 Earnings Call Transcript
Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...
Morningstar1d
Invesco Diversified Dividend A
Schlossberg also shook up leadership of key functions that support investment teams, including investment risk, operations, product ... legacy holdings such as Merck& Co MRK helping buoy the ...
Morningstar1d
Invesco Diversified Dividend Investor
Schlossberg also shook up leadership of key functions that support investment teams, including investment risk, operations, product ... legacy holdings such as Merck& Co MRK helping buoy the ...
7MRK : Decoding Merck & Co's Options Activity: What'...
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...
Yahoo Finance6d
Merck & Co. (MRK): ‘Forget It… It’s China,’ Jim Cramer on Vaccine Rollout Woes
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... have the potential to curb cravings for certain food products. Cramer pointed to beloved brands like Hershey ...
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Insider Monkey6d
Merck & Co. (MRK): ‘Forget It… It’s China,’ Jim Cramer on Vaccine Rollout Woes
We recently published a list of Jim Cramer Discussed These 12 Stocks Recently. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other stocks that ...
Yahoo Finance5d
TD Cowen cuts Merck stock to hold on uncertainty around Keytruda, Gardasil
Merck’s earnings estimates for 2025-2030 were lowered, with 2030 EPS now forecast to be significantly below 2024 levels. TD Cowen cut its price target on Merck from $121 to $100, citing weaker ...
Business Insider6d
Merck downgraded to Hold from Buy at TD Cowen
TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...